BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tarantino G, Conca P, Pasanisi F, Ariello M, Mastrolia M, Arena A, Tarantino M, Scopacasa F, Vecchione R. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol. 2009;21:504-511. [PMID: 19318968 DOI: 10.1097/meg.0b013e3283229b40] [Cited by in Crossref: 103] [Cited by in F6Publishing: 55] [Article Influence: 9.4] [Reference Citation Analysis]
Number Citing Articles
1 Krizanac M, Mass Sanchez PB, Weiskirchen R, Asimakopoulos A. A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma. Int J Mol Sci 2021;22:2865. [PMID: 33799862 DOI: 10.3390/ijms22062865] [Reference Citation Analysis]
2 Zhang H, Gao C, Fang L, Yao SK. Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus. World J Gastroenterol 2013;19:2395-403. [PMID: 23613635 DOI: 10.3748/wjg.v19.i15.2395] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lefere S, Van de Velde F, Devisscher L, Bekaert M, Raevens S, Verhelst X, Van Nieuwenhove Y, Praet M, Hoorens A, Van Steenkiste C, Van Vlierberghe H, Lapauw B, Geerts A. Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease. Int J Obes (Lond) 2017;41:1207-13. [PMID: 28461687 DOI: 10.1038/ijo.2017.102] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
4 Tarantino G, Citro V, Conca P, Riccio A, Tarantino M, Capone D, Cirillo M, Lobello R, Iaccarino V. What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis? BMC Gastroenterol. 2009;9:89. [PMID: 19930687 DOI: 10.1186/1471-230x-9-89] [Cited by in Crossref: 64] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
5 Mei L, Tang Y, Li M, Yang P, Liu Z, Yuan J, Zheng P. Co-Administration of Cholesterol-Lowering Probiotics and Anthraquinone from Cassia obtusifolia L. Ameliorate Non-Alcoholic Fatty Liver. PLoS One 2015;10:e0138078. [PMID: 26375281 DOI: 10.1371/journal.pone.0138078] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
6 Tarantino G, Spanò A, Loi G, Parisi A, Tarantino M, Brancaccio G, Gaeta GB, Riccio A. Is spleen circulation impaired in systemic sclerosis and what is the role of liver fibrosis? World J Gastroenterol. 2011;17:1606-1613. [PMID: 21472128 DOI: 10.3748/wjg.v17.i12.1606] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
7 Balato N, Napolitano M, Ayala F, Patruno C, Megna M, Tarantino G. Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation. World J Gastroenterol 2015;21:6892-7. [PMID: 26078565 DOI: 10.3748/wjg.v21.i22.6892] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
8 Tarantino G, Savastano S, Capone D, Colao A. Spleen: A new role for an old player? World J Gastroenterol. 2011;17:3776-3784. [PMID: 21987619 DOI: 10.3748/wjg.v17.i33.3776] [Cited by in CrossRef: 72] [Cited by in F6Publishing: 65] [Article Influence: 8.0] [Reference Citation Analysis]
9 Obika M, Noguchi H. Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res. 2012;2012:145754. [PMID: 22110476 DOI: 10.1155/2012/145754] [Cited by in Crossref: 114] [Cited by in F6Publishing: 102] [Article Influence: 11.4] [Reference Citation Analysis]
10 Abenavoli L, Milic N, Di Renzo L, Preveden T, Medić-Stojanoska M, De Lorenzo A. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World J Gastroenterol 2016;22:7006-16. [PMID: 27610012 DOI: 10.3748/wjg.v22.i31.7006] [Cited by in CrossRef: 95] [Cited by in F6Publishing: 85] [Article Influence: 23.8] [Reference Citation Analysis]
11 Tarantino G, Finelli C. Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease. World J Gastroenterol. 2013;19:6735-6743. [PMID: 24187449 DOI: 10.3748/wjg.v19.i40.6735] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 37] [Article Influence: 6.4] [Reference Citation Analysis]
12 Tarantino G, Colicchio P, Conca P, Finelli C, Di Minno MN, Tarantino M, Capone D, Pasanisi F. Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively? J Inflamm (Lond). 2009;6:6. [PMID: 19291292 DOI: 10.1186/1476-9255-6-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
13 Arora A, Sharma P. Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease. J Clin Exp Hepatol. 2012;2:145-155. [PMID: 25755423 DOI: 10.1016/s0973-6883(12)60103-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
14 Dowman JK, Tomlinson JW, Newsome PN. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2011;33:525-540. [PMID: 21198708 DOI: 10.1111/j.1365-2036.2010.04556.x] [Cited by in Crossref: 195] [Cited by in F6Publishing: 168] [Article Influence: 17.7] [Reference Citation Analysis]
15 Pearce SG, Thosani NC, Pan JJ. Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD. Biomark Res. 2013;1:7. [PMID: 24252302 DOI: 10.1186/2050-7771-1-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 6.5] [Reference Citation Analysis]
16 Tarantino G, Citro V, Capone D. Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy. J Clin Med. 2019;9. [PMID: 31861591 DOI: 10.3390/jcm9010015] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 18.5] [Reference Citation Analysis]
17 Tarantino G, Scopacasa F, Colao A, Capone D, Tarantino M, Grimaldi E, Savastano S. Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease. World J Gastroenterol. 2011;17:5280-5288. [PMID: 22219597 DOI: 10.3748/wjg.v17.i48.5280] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
18 Papageorgiou MV, Hadziyannis E, Tiniakos D, Georgiou A, Margariti A, Kostas A, Papatheodoridis GV. Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease. Ann Gastroenterol 2017;30:209-16. [PMID: 28243042 DOI: 10.20524/aog.2016.0107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
19 Wang Y, Li J, Zhuge L, Su D, Yang M, Tao S, Li J. Comparison between the efficacies of curcumin and puerarin in C57BL/6 mice with steatohepatitis induced by a methionine- and choline-deficient diet. Exp Ther Med 2014;7:663-8. [PMID: 24520264 DOI: 10.3892/etm.2013.1461] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
20 Stojsavljević S, Gomerčić Palčić M, Virović Jukić L, Smirčić Duvnjak L, Duvnjak M. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 2014;20:18070-91. [PMID: 25561778 DOI: 10.3748/wjg.v20.i48.18070] [Cited by in CrossRef: 174] [Cited by in F6Publishing: 144] [Article Influence: 29.0] [Reference Citation Analysis]
21 Raghu C, Ekena J, Cullen JM, Webb CB, Trepanier LA. Evaluation of potential serum biomarkers of hepatic fibrosis and necroinflammatory activity in dogs with liver disease. J Vet Intern Med 2018;32:1009-18. [PMID: 29485210 DOI: 10.1111/jvim.15064] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
22 Wu SJ, Zou H, Zhu GQ, Wang LR, Zhang Q, Shi KQ, Han JB, Huang WJ, Braddock M, Chen YP, Zheng MH. Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver disease. Medicine (Baltimore) 2015;94:e842. [PMID: 25984671 DOI: 10.1097/MD.0000000000000842] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
23 Tarantino G, Pizza G, Colao A, Pasanisi F, Conca P, Colicchio P, Finelli C, Contaldo F, Di Somma C, Savastano S. Hepatic steatosis in overweight/obese females: new screening method for those at risk. World J Gastroenterol. 2009;15:5693-5699. [PMID: 19960566 DOI: 10.3748/wjg.15.5693] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
24 Filozof C, Goldstein BJ, Williams RN, Sanyal A. Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway. Drugs 2015;75:1373-92. [PMID: 26201461 DOI: 10.1007/s40265-015-0437-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 9.4] [Reference Citation Analysis]
25 Tutunchi H, Naeini F, Saghafi-Asl M, Farrin N, Monshikarimi A, Ostadrahimi A. Effects of oleoylethanolamide supplementation on atherogenic indices and hematological parameters in patients with nonalcoholic fatty liver disease: A clinical trial. Health Promot Perspect 2020;10:373-82. [PMID: 33312933 DOI: 10.34172/hpp.2020.56] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
26 Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Rotellar F, Valentí V, Silva C, Gil MJ, Salvador J, Frühbeck G. Increased tenascin C and Toll-like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity. J Clin Endocrinol Metab 2012;97:E1880-9. [PMID: 22851489 DOI: 10.1210/jc.2012-1670] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.2] [Reference Citation Analysis]
27 Di Minno MN, Tufano A, Rusolillo A, Di Minno G, Tarantino G. High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism. World J Gastroenterol. 2010;16:6119-6122. [PMID: 21182227 DOI: 10.3748/wjg.v16.i48.6119] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
28 Gupta AK, Johnson WD. Prediabetes and prehypertension in disease free obese adults correlate with an exacerbated systemic proinflammatory milieu. J Inflamm (Lond) 2010;7:36. [PMID: 20659335 DOI: 10.1186/1476-9255-7-36] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
29 Laugero KD, Adkins Y, Mackey BE, Kelley DS. Emotion-Based Cognition in Mice Is Differentially Influenced by Dose and Chemical Form of Dietary Docosahexaenoic Acid. Nutrients 2017;9:E993. [PMID: 28885568 DOI: 10.3390/nu9090993] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
30 Tarantino G, Scalera A, Finelli C. Liver-spleen axis: intersection between immunity, infections and metabolism. World J Gastroenterol. 2013;19:3534-3542. [PMID: 23801854 DOI: 10.3748/wjg.v19.i23.3534] [Cited by in CrossRef: 68] [Cited by in F6Publishing: 42] [Article Influence: 8.5] [Reference Citation Analysis]
31 Tyrovolas S, Panagiotakos DB, Georgousopoulou EN, Chrysohoou C, Skoumas J, Pan W, Tousoulis D, Pitsavos C. The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study. Therap Adv Gastroenterol 2019;12:1756284819858039. [PMID: 31258620 DOI: 10.1177/1756284819858039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
32 Oh H, Jun DW, Saeed WK, Nguyen MH. Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment. Clin Mol Hepatol. 2016;22:327-335. [PMID: 27729634 DOI: 10.3350/cmh.2016.0049] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
33 Tarantino G, Caputi A. JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease. World J Gastroenterol 2011;17:3785-94. [PMID: 21987620 DOI: 10.3748/wjg.v17.i33.3785] [Cited by in CrossRef: 81] [Cited by in F6Publishing: 74] [Article Influence: 9.0] [Reference Citation Analysis]
34 Tarantino G, Savastano S, Colao A. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol. 2010;16:4773-4783. [PMID: 20939105 DOI: 10.3748/wjg.v16.i38.4773.] [Reference Citation Analysis]
35 Wang S, Zhang C, Zhang G, Yuan Z, Liu Y, Ding L, Sun X, Jia H, Xue F. Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study. BMJ Open 2016;6:e010342. [PMID: 27251683 DOI: 10.1136/bmjopen-2015-010342] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
36 Murotomi K, Arai S, Uchida S, Endo S, Mitsuzumi H, Tabei Y, Yoshida Y, Nakajima Y. Involvement of splenic iron accumulation in the development of nonalcoholic steatohepatitis in Tsumura Suzuki Obese Diabetes mice. Sci Rep 2016;6:22476. [PMID: 26932748 DOI: 10.1038/srep22476] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
37 Fierbinteanu-Braticevici C, Dina I, Petrisor A, Tribus L, Negreanu L, Carstoiu C. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol 2010;16:4784-91. [PMID: 20939106 DOI: 10.3748/wjg.v16.i38.4784] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
38 Di Minno MN, Russolillo A, Lupoli R, Ambrosino P, Di Minno A, Tarantino G. Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. World J Gastroenterol 2012;18:5839-47. [PMID: 23139599 DOI: 10.3748/wjg.v18.i41.5839] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 84] [Article Influence: 12.3] [Reference Citation Analysis]
39 Lee SR, Kwon SW, Kaya P, Lee YH, Lee JG, Kim G, Lee GS, Baek IJ, Hong EJ. Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis. Sci Rep 2018;8:15711. [PMID: 30356113 DOI: 10.1038/s41598-018-34148-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
40 Zhou W. Pathogenesis of liver cirrhosis. WJG 2014;20:7312. [DOI: 10.3748/wjg.v20.i23.7312] [Cited by in CrossRef: 193] [Cited by in F6Publishing: 167] [Article Influence: 27.6] [Reference Citation Analysis]
41 Arias-Loste MT, Iruzubieta P, Puente Á, Ramos D, Santa Cruz C, Estébanez Á, Llerena S, Alonso-Martín C, San Segundo D, Álvarez L, López Useros A, Fábrega E, López-Hoyos M, Crespo J. Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease. Int J Mol Sci 2016;17:E1878. [PMID: 27834919 DOI: 10.3390/ijms17111878] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
42 Hashemi Kani A, Alavian SM, Haghighatdoost F, Azadbakht L. Diet macronutrients composition in nonalcoholic Fatty liver disease: a review on the related documents. Hepat Mon. 2014;14:e10939. [PMID: 24693306 DOI: 10.5812/hepatmon.10939] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
43 Scalera A, Di Minno MN, Tarantino G. What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol. 2013;19:5402-5420. [PMID: 24023483 DOI: 10.3748/wjg.v19.i33.5402] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
44 Tarantino G, Savastano S, Colao A. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol. 2010;16:4773-4783. [PMID: 20939105 DOI: 10.3748/wjg.v16.i38.4773] [Cited by in CrossRef: 111] [Cited by in F6Publishing: 107] [Article Influence: 11.1] [Reference Citation Analysis]
45 Savastano S, Di Somma C, Pizza G, De Rosa A, Nedi V, Rossi A, Orio F, Lombardi G, Colao A, Tarantino G. Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females. J Transl Med. 2011;9:136. [PMID: 21846339 DOI: 10.1186/1479-5876-9-136] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
46 Tarantino G, Finelli C, Colao A, Capone D, Tarantino M, Grimaldi E, Chianese D, Gioia S, Pasanisi F, Contaldo F. Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase. J Transl Med. 2012;10:50. [PMID: 22424154 DOI: 10.1186/1479-5876-10-50] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
47 Fabbrini E, Magkos F. Hepatic Steatosis as a Marker of Metabolic Dysfunction. Nutrients 2015;7:4995-5019. [PMID: 26102213 DOI: 10.3390/nu7064995] [Cited by in Crossref: 90] [Cited by in F6Publishing: 74] [Article Influence: 15.0] [Reference Citation Analysis]
48 Chakraborty D, Wang J. Nonalcoholic fatty liver disease and colorectal cancer: Correlation and missing links. Life Sci 2020;262:118507. [PMID: 33017572 DOI: 10.1016/j.lfs.2020.118507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
49 Robert S, Gicquel T, Bodin A, Lagente V, Boichot E. Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate Cells. PLoS One 2016;11:e0153118. [PMID: 27046197 DOI: 10.1371/journal.pone.0153118] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 14.8] [Reference Citation Analysis]
50 Shin SK, Cho HW, Song SE, Song DK. Catalase and nonalcoholic fatty liver disease. Pflugers Arch 2018;470:1721-37. [PMID: 30120555 DOI: 10.1007/s00424-018-2195-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 6.3] [Reference Citation Analysis]
51 Kupčová V, Fedelešová M, Bulas J, Kozmonová P, Turecký L. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD. Int J Environ Res Public Health 2019;16:E3570. [PMID: 31554274 DOI: 10.3390/ijerph16193570] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
52 Cui G, Martin RC, Liu X, Zheng Q, Pandit H, Zhang P, Li W, Li Y. Serological biomarkers associate ultrasound characteristics of steatohepatitis in mice with liver cancer. Nutr Metab (Lond) 2018;15:71. [PMID: 30323853 DOI: 10.1186/s12986-018-0304-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
53 Fierbinteanu-Braticevici C, Dina I, Petrisor A, Tribus L, Negreanu L, Carstoiu C. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol. 2010;16:4784-4791. [PMID: 20939106 DOI: 10.3748/wjg.v16i38.4784] [Reference Citation Analysis]
54 Tarantino G, Citro V, Conforti P, Balsano C, Capone D. Is There a Link between Basal Metabolic Rate, Spleen Volume and Hepatic Growth Factor Levels in Patients with Obesity-Related NAFLD? J Clin Med 2019;8:E1510. [PMID: 31547124 DOI: 10.3390/jcm8101510] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
55 Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM. 2010;103:71-83. [PMID: 19914930 DOI: 10.1093/qjmed/hcp158] [Cited by in Crossref: 392] [Cited by in F6Publishing: 339] [Article Influence: 32.7] [Reference Citation Analysis]